Alar Pharmaceuticals Statistics

Total Valuation

TPEX:6785 has a market cap or net worth of TWD 7.82 billion. The enterprise value is 5.39 billion.

Market Cap	7.82B
Enterprise Value	5.39B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6785 has 66.80 million shares outstanding. The number of shares has increased by 16.08% in one year.

Current Share Class	n/a
Shares Outstanding	66.80M
Shares Change (YoY)	+16.08%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	24.57%
Owned by Institutions (%)	4.97%
Float	36.62M

Valuation Ratios

The trailing PE ratio is 430.14.

PE Ratio	430.14
Forward PE	n/a
PS Ratio	1,343.58
PB Ratio	3.14
P/TBV Ratio	3.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	296.38
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-77.11

Financial Position

The company has a current ratio of 44.33, with a Debt / Equity ratio of 0.00.

Current Ratio	44.33
Quick Ratio	44.14
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-2,516.44

Financial Efficiency

Return on equity (ROE) is 1.07% and return on invested capital (ROIC) is -2.50%.

Return on Equity (ROE)	1.07%
Return on Assets (ROA)	-2.41%
Return on Invested Capital (ROIC)	-2.50%
Return on Capital Employed (ROCE)	-2.72%
Revenue Per Employee	215,444
Profits Per Employee	672,963
Employee Count	27
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.19% in the last 52 weeks. The beta is 0.12, so TPEX:6785's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-61.19%
50-Day Moving Average	139.93
200-Day Moving Average	166.16
Relative Strength Index (RSI)	37.54
Average Volume (20 Days)	171,717

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6785 had revenue of TWD 5.82 million and earned 18.17 million in profits. Earnings per share was 0.27.

Revenue	5.82M
Gross Profit	3.79M
Operating Income	-67.94M
Pretax Income	37.05M
Net Income	18.17M
EBITDA	-65.43M
EBIT	-67.94M
Earnings Per Share (EPS)	0.27

Full Income Statement

Balance Sheet

The company has 2.43 billion in cash and 604,000 in debt, giving a net cash position of 2.43 billion or 36.38 per share.

Cash & Cash Equivalents	2.43B
Total Debt	604,000
Net Cash	2.43B
Net Cash Per Share	36.38
Equity (Book Value)	2.49B
Book Value Per Share	37.30
Working Capital	2.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.67 million and capital expenditures -32.17 million, giving a free cash flow of -69.84 million.

Operating Cash Flow	-37.67M
Capital Expenditures	-32.17M
Free Cash Flow	-69.84M
FCF Per Share	-1.05

Full Cash Flow Statement

Margins

Gross margin is 65.15%, with operating and profit margins of -1,168.02% and 312.36%.

Gross Margin	65.15%
Operating Margin	-1,168.02%
Pretax Margin	636.91%
Profit Margin	312.36%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.22%.

Dividend Per Share	0.25
Dividend Yield	0.22%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	551.46%
Buyback Yield	-16.08%
Shareholder Yield	-15.86%
Earnings Yield	0.23%
FCF Yield	-0.89%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6785 has an Altman Z-Score of 145.54.

Altman Z-Score	145.54
Piotroski F-Score	n/a